Literature DB >> 23182131

Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly.

Priya Rajagopalan1, Helga Refsum, Xue Hua, Arthur W Toga, Clifford R Jack, Michael W Weiner, Paul M Thompson.   

Abstract

Poor kidney function is associated with increased risk of cognitive decline and generalized brain atrophy. Chronic kidney disease impairs glomerular filtration rate, and this deterioration is indicated by elevated blood levels of kidney biomarkers such as creatinine and cystatin C. Here we hypothesized that impaired renal function would be associated with brain deficits in regions vulnerable to neurodegeneration. Using tensor-based morphometry, we related patterns of brain volumetric differences to creatinine, cystatin C levels, and glomerular filtration rate in a large cohort of 738 (mean age, 75.5 ± 6.8 years; 438 men, 300 women) elderly Caucasian subjects scanned as part of the Alzheimer's Disease Neuroimaging Initiative. Elevated kidney biomarkers were associated with volume deficits in the white matter region of the brain. All 3 renal parameters in our study showed significant associations consistently with a region that corresponds with the anterior limb of internal capsule, bilaterally. This is the first study to report a marked profile of structural alterations in the brain associated with elevated kidney biomarkers, helping us to explain the cognitive deficits.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182131      PMCID: PMC3603573          DOI: 10.1016/j.neurobiolaging.2012.10.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  38 in total

1.  Developing guidelines for chronic kidney disease: we should include all of the outcomes.

Authors:  Katrin Uhlig; Andrew S Levey
Journal:  Ann Intern Med       Date:  2012-04-17       Impact factor: 25.391

2.  Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.

Authors:  Manjula Kurella; Glenn M Chertow; Linda F Fried; Steven R Cummings; Tamara Harris; Eleanor Simonsick; Suzanne Satterfield; Hilsa Ayonayon; Kristine Yaffe
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

3.  Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease.

Authors:  B R Reed; J L Eberling; D Mungas; M W Weiner; W J Jagust
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

4.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

5.  Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry.

Authors:  April J Ho; Xue Hua; Suh Lee; Alex D Leow; Igor Yanovsky; Boris Gutman; Ivo D Dinov; Natasha Leporé; Jason L Stein; Arthur W Toga; Clifford R Jack; Matt A Bernstein; Eric M Reiman; Danielle J Harvey; John Kornak; Norbert Schuff; Gene E Alexander; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

Review 6.  Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage.

Authors:  Gary F Mitchell
Journal:  J Appl Physiol (1985)       Date:  2008-09-04

7.  Kidney function is related to cerebral small vessel disease.

Authors:  M Arfan Ikram; Meike W Vernooij; Albert Hofman; Wiro J Niessen; Aad van der Lugt; Monique M B Breteler
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

8.  Asymptomatic cerebral lacunae in patients with chronic kidney disease.

Authors:  Shuzo Kobayashi; Toshio Ikeda; Hidekazu Moriya; Takayasu Ohtake; Hiromichi Kumagai
Journal:  Am J Kidney Dis       Date:  2004-07       Impact factor: 8.860

Review 9.  Cognitive function in chronic kidney disease.

Authors:  Magdalena Madero; Ambreen Gul; Mark J Sarnak
Journal:  Semin Dial       Date:  2008 Jan-Feb       Impact factor: 3.455

10.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging.

Authors:  P Scheltens; F Barkhof; D Leys; E C Wolters; R Ravid; W Kamphorst
Journal:  Neurology       Date:  1995-05       Impact factor: 9.910

View more
  8 in total

1.  Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study.

Authors:  Kristine Yaffe; Manjula Kurella-Tamura; Lynn Ackerson; Tina D Hoang; Amanda H Anderson; Mark Duckworth; Alan S Go; Marie Krousel-Wood; John W Kusek; James P Lash; Akinlolu Ojo; Nancy Robinson; Ashwini R Sehgal; James H Sondheimer; Susan Steigerwalt; Raymond R Townsend
Journal:  J Am Geriatr Soc       Date:  2014-08-14       Impact factor: 5.562

Review 2.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

3.  Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Sarah K Madsen; Priya Rajagopalan; Shantanu H Joshi; Arthur W Toga; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2014-08-30       Impact factor: 4.673

4.  The effects of cystatin C and alkaline phosphatase changes on cognitive function 12-months after bariatric surgery.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Ross D Crosby; James E Mitchell; John Gunstad
Journal:  J Neurol Sci       Date:  2014-07-22       Impact factor: 3.181

Review 5.  Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies.

Authors:  Kay Deckers; Ileana Camerino; Martin P J van Boxtel; Frans R J Verhey; Kate Irving; Carol Brayne; Miia Kivipelto; John M Starr; Kristine Yaffe; Peter W de Leeuw; Sebastian Köhler
Journal:  Neurology       Date:  2016-12-14       Impact factor: 9.910

6.  Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.

Authors:  Agustín Ruiz; Pedro Pesini; Ana Espinosa; Virginia Pérez-Grijalba; Sergi Valero; Oscar Sotolongo-Grau; Montserrat Alegret; Inmaculada Monleón; Asunción Lafuente; Mar Buendía; Marta Ibarria; Susana Ruiz; Isabel Hernández; Itziar San José; Lluís Tárraga; Mercè Boada; Manuel Sarasa
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Measurement of creatinine in human plasma using a functional porous polymer structure sensing motif.

Authors:  Sitansu Sekhar Nanda; Seong Soo A An; Dong Kee Yi
Journal:  Int J Nanomedicine       Date:  2015-08-25

8.  Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study.

Authors:  Danny A Kanhai; Dominique P V de Kleijn; L Jaap Kappelle; Cuno S P M Uiterwaal; Yolanda van der Graaf; Gerard Pasterkamp; Mirjam I Geerlings; Frank L J Visseren
Journal:  BMJ Open       Date:  2014-01-14       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.